Curtana Pharmaceuticals Company
Curtana is a biopharmaceutical company that has developed therapies for the treatment of the most aggressive types of brain cancer.
Total Funding:
52288
Investor Type:
Seed
Technology:
Small Molecules
Last Funding Type:
Grant
Estimated Revenue:
Less than $1M
Founded Date:
2013
Industry:
Biopharma, Biotechnology, Pharmaceutical
Employee Number:
1-10
Last Funding Date:
2017
Funding Status:
Seed
Headquarters:
Austin, Texas, United States
Investors Number:
3